Human Metabolome Technologies (TSE:6090) EPS (Basic): 円35.70 (TTM As of Mar. 2026)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Human Metabolome Technologies Inc TSE:6090

62 GF Score

Price 円625.00

GF Value 円693.69

Valuation Modestly Undervalued

3 Warning Signs

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

What is Human Metabolome Technologies EPS (Basic)?

Human Metabolome Technologies TSE:6090 -3.10% 62 EPS (Basic) is 円35.70 as of Mar. 2026. GuruFocus rates TSE:6090 with a GF Score™ of 62/100 and a GF Value™ of 円693.69 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Human Metabolome Technologies's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was 円21.61. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was 円35.70.

Human Metabolome Technologies's EPS (Diluted) for the three months ended in Mar. 2026 was 円21.61. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円35.70.

Human Metabolome Technologies's EPS without NRI for the three months ended in Mar. 2026 was 円21.73. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 33.03.

During the past 12 months, Human Metabolome Technologies's average EPS without NRIGrowth Rate was -71.50% per year. During the past 3 years, the average EPS without NRI Growth Rate was -4.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Human Metabolome Technologies's highest 3-Year average EPS without NRI Growth Rate was 51.70% per year. The lowest was -68.10% per year. And the median was 4.85% per year.

Try GuruFocus Premium free for 7 days

Unlock GF Score, GF Value, 30-Y financials, and pro screeners.

Get Started →

Human Metabolome Technologies (TSE:6090) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Human Metabolome Technologies EPS (Basic) Related Terms

Human Metabolome Technologies EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Human Metabolome Technologies's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Human Metabolome Technologies EPS (Basic) Chart

Human Metabolome Technologies Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

EPS (Basic)

Get a 7-Day Free Trial

9.87

45.39

48.39

41.14

43.67

Human Metabolome Technologies Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26	Jun26
EPS (Basic)	Get a 7-Day Free Trial															-7.86	-17.10	24.84	21.61	6.35

62GF Score

Human Metabolome Technologies Inc TSE:6090

EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

Human Metabolome Technologies EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Human Metabolome Technologies's Basic EPS for the fiscal year that ended in Jun. 2025 is calculated as

Basic EPS (A: Jun. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(256.42	-	0)	/	5.872
	=	43.67

Human Metabolome Technologies's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(121.857	-	0)	/	5.645
	=	21.59

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円35.70

Frequently Asked Questions Learn more about EPS (Basic) →

What does a EPS (Basic) of 円35.70 mean?

Human Metabolome Technologies (TSE:6090) has a EPS (Basic) of 円35.70 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Human Metabolome Technologies and its competitors.

Is Human Metabolome Technologies' EPS (Basic) too high?

Human Metabolome Technologies' current EPS (Basic) is 円35.70. Overall, Human Metabolome Technologies has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Human Metabolome Technologies' EPS (Basic) compare to TMO and DHR?

Human Metabolome Technologies' EPS (Basic) of 円35.70 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EPS (Basic) for a Medical Diagnostics & Research company?

A good EPS (Basic) depends on the Medical Diagnostics & Research industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EPS (Basic) mean?

A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Human Metabolome Technologies and its competitors. Human Metabolome Technologies's current EPS (Basic) is 円35.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Human Metabolome Technologies stock overvalued right now?

Based on GuruFocus' analysis, Human Metabolome Technologies (TSE:6090) is currently considered Modestly Undervalued. The stock's GF Value™ is 円693.69, compared to a current price of 円625.00 — trading 9.9% below its estimated fair value. The current EPS (Basic) is 円35.70. Human Metabolome Technologies' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EPS (Basic) calculated?

EPS (Basic) is calculated from a company's financial statements. For Human Metabolome Technologies (TSE:6090), the current EPS (Basic) is 円35.70 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Human Metabolome Technologies (TSE:6090) Overvalued in 2026?

Based on GuruFocus' analysis, Human Metabolome Technologies stock appears to be undervalued. The current stock price of 円625.00 is trading 9.9% below its estimated GF Value™ of 円693.69. GuruFocus considers Human Metabolome Technologies to be Modestly Undervalued.

Key valuation signals for TSE:6090:

EPS (Basic): 円35.70
GF Value™: 円693.69 vs. price of 円625.00 (9.9% below fair value)
GF Score™: 62/100 with 3 warning signs

No single metric tells the full story. See the TSE:6090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →